IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Carlos Fung who wrote (9)	9/11/1996 1:58:00 PM
From: Vinnie Sebastian	of 1510

Do you think the news today will bring IMNR higher? September 11,96 Immune Response Unveils Phase I Arthritis Treatment Results CARLSBAD, Calif. (Dow Jones)--Immune Response Corp. (IMNR) said physicians in the company's phase I rheumatoid arthritis clinical trial observed that patients using the company's treatment experienced a decrease in joint swelling and pain. In March, the company said its treatment for rheumatoid arthritis is designed to ''turn off'' the specific immune system cells that it believes cause the ailment, In a press release, Immune Response said 15 patients with moderate to severe rheumatoid arthritis were given intramuscular injections of the rheumatoid arthritis treatment, followed by a second injection four weeks later. These patients were then followed for a total of 48 weeks. At the conclusion, physicians observed a decrease in joint swelling and pain beginning at the first four week follow-up visit, the company said. The company said the product was well tolerated and no serious treatment-related adverse events were observed. The company also said results of its phase II trial are expected to be available by year-end. Immune Response Corp. is a biopharmaceutical company. -Vin

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next